Home

REMICADE - 100mg - 1

ATC	B/G	Ingredients	code	Registration Nb	Name	Dosage	Presentation	Form	Route	Agent	Laboratory	Country	Price	Pharmacist Margin	Stratum	Responsible Party Name	Responsible Party Country	Exch_date	%SUBSIDY
L04AB02	BioTech	Infliximab - 100mg	4028	23638/06	REMICADE	100mg	1	Injectable concentrated powder for solution	Infusion	Abela Frères S.A.L.	Cilag AG	Switzerland	12,565,953 L.L	19.35	D	Janssen Biologics BV	The Netherlands	05/02/20	70

ATC	B/G	Ingredients	code	Registration Nb	Name	Dosage	Presentation	Form	Route	Agent	Laboratory	Country	Price	Pharmacist Margin	Stratum	Responsible Party Name	Responsible Party Country	Exch_date	%SUBSIDY
L04AB02	BioTech	Infliximab - 100mg	10266	48720/1	IXIFI	100mg	1	Injectable powder for concentrate for solution	Infusion	Food & Drug Corporation FDC	Pfizer Manufacturing Belgium NV	Belgium	9,978,814 L.L	19.35	D	Pfizer Japan Inc.	Japan	05/02/20	70
L04AB02	BioTech	Infliximab - 100mg	9859	66716/1	REMSIMA	100mg	1	Injectable concentrated powder for solution	Infusion	Droguerie Mercury S.A.L.	Celltrion Inc., secondary packed by Hikma Pharmaceuticals, Jordan	Korea	10,423,659 L.L	19.35	D	Hikma Pharmaceuticals	Jordan	05/02/20	70
L04AB02	BioTech	Infliximab - 100mg	4028/945	23638/06	REMICADE	100mg	1	Injectable concentrated powder for solution	Infusion	Abela Frères S.A.L.	Cilag AG	Switzerland	30,111,023 L.L	19.35	D	Janssen Biologics BV	The Netherlands	05/02/20	0
L04AB02	BioTech	Infliximab - 100mg	9859/945	66716/1	REMSIMA	100mg	1	Injectable concentrated powder for solution	Infusion	Droguerie Mercury S.A.L.	Celltrion Inc., secondary packed by Hikma Pharmaceuticals, Jordan	Korea	24,977,587 L.L	19.35	D	Hikma Pharmaceuticals	Jordan	05/02/20	0
L04AB02	BioTech	Infliximab - 100mg	10266/945	48720/1	IXIFI	100mg	1	Injectable powder for concentrate for solution	Infusion	Food & Drug Corporation FDC	Pfizer Manufacturing Belgium NV	Belgium	23,911,751 L.L	19.35	D	Pfizer Japan Inc.	Japan	05/02/20	0